← Shandong Yisheng Livestock & Poultry Breeding overview

Shandong Yisheng Livestock & Poultry Breeding vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Shandong Yisheng Livestock & Poultry Breeding Co Ltd (002458.CS)

Q3 20266 Jul – 23 Jul 2026

▲4

Yisheng profit surges 4,897% on broiler boom, record dividend

Hog price rally lifts livestock sector National average hog prices jumped 13% week-on-week to above 11 yuan per kilogram, with breeding sow capacity cuts continuing. This sector-wide rally pulled Yisheng shares up nearly 6% in a single session, as investors bet on a new livestock cycle lifting all animal farming stocks.
Explains the early-period sector rally that first moved Yisheng shares.
Half-year profit explodes on broiler volume and price gains Yisheng reported first-half net profit of 308 million yuan, up 4,897% year-on-year, on revenue up 28%. Parent-stock broiler breeders and commercial chicks both sold more at higher prices. This is the core driver: the white-feather broiler business is firing on all cylinders, proving the earnings power behind the stock.
The earnings surge is the single biggest fundamental driver of the stock.
Record mid-term dividend signals confidence The company proposed a cash dividend of 1.5 yuan per 10 shares, a total payout of 211 million yuan, potentially its largest-ever interim dividend. Paying out roughly two-thirds of profit shows management confidence in cash generation and gives income-focused investors a concrete reason to hold the stock.
Dividend policy directly affects shareholder returns and stock appeal.
Breeding pig business scales up fast Breeding pig sales hit 73,557 in the first half, up over 90% year-on-year, pushing Yisheng into the top tier of national breeding pig enterprises. This adds a second growth engine beyond broilers, diversifying revenue and reducing reliance on a single poultry cycle.
New business line broadens the growth story beyond broilers.

July 20266 Jul – 23 Jul 2026

▲4

Yisheng profit surges 4,897% on broiler boom, record dividend

Hog price rally lifts livestock sector National average hog prices jumped 13% week-on-week to above 11 yuan per kilogram, with breeding sow capacity cuts continuing. This sector-wide rally pulled Yisheng shares up nearly 6% in a single session, as investors bet on a new livestock cycle lifting all animal farming stocks.
Explains the early-period sector rally that first moved Yisheng shares.
Half-year profit explodes on broiler volume and price gains Yisheng reported first-half net profit of 308 million yuan, up 4,897% year-on-year, on revenue up 28%. Parent-stock broiler breeders and commercial chicks both sold more at higher prices. This is the core driver: the white-feather broiler business is firing on all cylinders, proving the earnings power behind the stock.
The earnings surge is the single biggest fundamental driver of the stock.
Record mid-term dividend signals confidence The company proposed a cash dividend of 1.5 yuan per 10 shares, a total payout of 211 million yuan, potentially its largest-ever interim dividend. Paying out roughly two-thirds of profit shows management confidence in cash generation and gives income-focused investors a concrete reason to hold the stock.
Dividend policy directly affects shareholder returns and stock appeal.
Breeding pig business scales up fast Breeding pig sales hit 73,557 in the first half, up over 90% year-on-year, pushing Yisheng into the top tier of national breeding pig enterprises. This adds a second growth engine beyond broilers, diversifying revenue and reducing reliance on a single poultry cycle.
New business line broadens the growth story beyond broilers.

Latest6 Jul – 23 Jul 2026

▲4

Yisheng profit surges 4,897% on broiler boom, record dividend

Hog price rally lifts livestock sector National average hog prices jumped 13% week-on-week to above 11 yuan per kilogram, with breeding sow capacity cuts continuing. This sector-wide rally pulled Yisheng shares up nearly 6% in a single session, as investors bet on a new livestock cycle lifting all animal farming stocks.
Explains the early-period sector rally that first moved Yisheng shares.
Half-year profit explodes on broiler volume and price gains Yisheng reported first-half net profit of 308 million yuan, up 4,897% year-on-year, on revenue up 28%. Parent-stock broiler breeders and commercial chicks both sold more at higher prices. This is the core driver: the white-feather broiler business is firing on all cylinders, proving the earnings power behind the stock.
The earnings surge is the single biggest fundamental driver of the stock.
Record mid-term dividend signals confidence The company proposed a cash dividend of 1.5 yuan per 10 shares, a total payout of 211 million yuan, potentially its largest-ever interim dividend. Paying out roughly two-thirds of profit shows management confidence in cash generation and gives income-focused investors a concrete reason to hold the stock.
Dividend policy directly affects shareholder returns and stock appeal.
Breeding pig business scales up fast Breeding pig sales hit 73,557 in the first half, up over 90% year-on-year, pushing Yisheng into the top tier of national breeding pig enterprises. This adds a second growth engine beyond broilers, diversifying revenue and reducing reliance on a single poultry cycle.
New business line broadens the growth story beyond broilers.

Danone SA (BN.PA)

Q3 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

July 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

Latest22 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.